{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T17:42:06Z","timestamp":1788975726018,"version":"build-2803163510"},"reference-count":52,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2022,11,23]],"date-time":"2022-11-23T00:00:00Z","timestamp":1669161600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p>Chronic hepatitis negatively affects persons living with HIV. While varying in their transmission efficiency, HIV, HBV, and HCV have shared routes of transmission. Available data suggest widely variable rates of HBV and HCV infections in HIV-infected populations across sub-Saharan Africa. With prolonged survival rates due to increased accessibility to antiretroviral drugs, HBV and HCV have the potential to complicate the prognosis of HIV co-infected patients by contributing significantly to continued morbidity and mortality. The study sought to determine the seroprevalence of HIV\/HBV and HIV\/HCV co-infections among HIV patients on antiretroviral therapy and to evaluate the effect of HIV\/HBV and HIV\/HCV co-infections on the immunologic and virologic responses of patients. A cross-sectional study in which samples were taken from 500 people living with HIV and attending ART clinic at the Fevers unit of the Korle Bu Teaching Hospital and tested for Hepatitis B Surface Antigen (HBsAg) and Hepatitis C virus antibody (HCV). CD4 cell counts and HIV-1 RNA levels were estimated as well. Data generated were analysed using IBM SPSS version 22. The seroprevalence of HIV\/HBV and HIV\/HCV co-infections among people living with HIV was 8.4% and 0.2% respectively. HIV\/HBV coinfection included 15\/42 (35.7%) males and 27\/42 (64.3%) females out of which the majority (97.6%) were in the 21\u201360 years old bracket. HIV\/HBV and HIV\/HCV co-infections have varied effects on the immunological and virological response of HIV patients on ART. The mean CD cell count was 361.0 \u00b1 284.0 in HIV\/HBV co-infected patients and 473.8 \u00b1 326.7 in HIV mono-infected patients. The mean HIV-1 RNA level was not significantly different (X<jats:sup>2<\/jats:sup> [df] = .057 [1]; <jats:italic>P<\/jats:italic> = .811) among HIV\/HBV co-infected patients (Log<jats:sub>10<\/jats:sub>2.9\u00b12.0 copies\/mL), compared to that of HIV mono-infected patients (Log<jats:sub>10<\/jats:sub>2.8\u00b12.1 copies\/mL) although HIV mono-infected patients had lower viral load levels. One-third (14\/42) of HIV\/HBV co-infected patients had virologic failure and the only HIV\/HCV co-infected patient showed viral suppression. 336\/500 (67.2%) patients had HIV-1 viral suppression (females [66.1%]; males [33.9%]) while 164\/500 (32.8%) had virologic failure (females [67.7%]; males [32.3%]). The mean CD4 count of patients with viral suppression and patients with virologic failure was 541.2 cells\/\u03bcL (95% CI 508.5\u2013573.8) and 309.9 cell\/\u03bcL (95% CI 261.9\u2013357.9) respectively.The study concludes that, HIV\/HBV and HIV\/HCV coinfections do not significantly affect the immunologic and virologic responses of patients who have initiated highly active antiretroviral therapy, and treatment outcomes were better in females than in males. There was no HBV\/HCV co-infection among patients.<\/jats:p>","DOI":"10.1371\/journal.pone.0278037","type":"journal-article","created":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T15:01:06Z","timestamp":1669302066000},"page":"e0278037","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":10,"title":["Seroprevalence and effect of HBV and HCV co-infections on the immuno-virologic responses of adult HIV-infected persons on anti-retroviral therapy"],"prefix":"10.1371","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1485-8580","authenticated-orcid":true,"given":"Lawrence","family":"Annison","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry","family":"Hackman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulina Franklin","family":"Eshun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Annison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Forson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Antwi-Baffour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2022,11,23]]},"reference":[{"key":"pone.0278037.ref001","article-title":"HIV\/AIDS. Fact Sheet World Health Organisation, Geneva, Switzerland","author":"WHO","year":"2018"},{"key":"pone.0278037.ref002","article-title":"Global HIV & AIDS statistics\u2013 2018 fact sheet","author":"UNAIDS","year":"2018","journal-title":"Joint United Nations Programme on HIV\/AIDS Geneva, Switzerland"},{"key":"pone.0278037.ref003","unstructured":"CDC. About HIV\/AIDS. HIV Basics. Centers for Disease Control and Prevention. 2019. https:\/\/www.cdc.gov\/hiv\/basics\/whatishiv.html."},{"key":"pone.0278037.ref004","author":"CDC","year":"2018","journal-title":"About HIV\/AIDS. HIV Basics. Centers for Disease Control and Prevention"},{"key":"pone.0278037.ref005","author":"A. Luetkemeyer","year":"2010","journal-title":"Hepatitis B and HIV Coinfection in HIV InSite Knowledge Base Chapter"},{"issue":"9963","key":"pone.0278037.ref006","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0140-6736(14)61682-2","article-title":"Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990\u20132013: A systematic analysis for the Global Burden of Disease Study 2013","volume":"385","author":"M Naghavi","year":"2015","journal-title":"Lancet"},{"issue":"1","key":"pone.0278037.ref007","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12916-014-0145-y","article-title":"Liver cirrhosis mortality in 187 countries between 1980 and 2010: A systematic analysis","volume":"12","author":"AA Mokdad","year":"2014","journal-title":"BMC Med"},{"key":"pone.0278037.ref008","article-title":"Hepatitis B. Fact Sheet World Health Organisation, Geneva, Switzerland","author":"WHO","year":"2022"},{"key":"pone.0278037.ref009","article-title":"Hepatitis C. Fact Sheet World Health Organization, Geneva, Switzerland","author":"WHO","year":"2017"},{"issue":"7","key":"pone.0278037.ref010","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/S1473-3099(15)00006-7","article-title":"Hepatitis C seroprevalence and HIV co-infection in sub-Saharan Africa: A systematic review and meta-analysis","volume":"15","author":"VB Rao","year":"2015","journal-title":"Lancet Infect Dis [Internet]."},{"issue":"4","key":"pone.0278037.ref011","doi-asserted-by":"crossref","first-page":"371","DOI":"10.2217\/fvl.13.11","article-title":"Viral hepatitis in resource-limited countries and access to antiviral therapies: Current and future challenges","volume":"8","author":"M Lemoine","year":"2013","journal-title":"Future Virol."},{"issue":"8","key":"pone.0278037.ref012","doi-asserted-by":"crossref","first-page":"e361","DOI":"10.1016\/S2352-3018(16)30087-X","article-title":"Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980\u20132015: the Global Burden of Disease Study 2015","volume":"3","author":"H Wang","year":"2016","journal-title":"Lancet HIV"},{"key":"pone.0278037.ref013","article-title":"HIV\/HBV and HIV\/HCV Co-infection in Sub-Saharan Africa: Transmission, Disease Outcomes, and Treatment Options.","author":"MW Sonderup","year":"2018","journal-title":"World Gastroenterology Organisation"},{"issue":"18","key":"pone.0278037.ref014","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.1097\/00002030-200012220-00011","article-title":"Hepatitis B and C virus co-infection and the risk for hepatotoxicity of highly active antiretroviral therapy in HIV-1 infection","volume":"14","author":"M Den Brinker","year":"2000","journal-title":"Aids"},{"issue":"7","key":"pone.0278037.ref015","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S1473-3099(15)00485-5","article-title":"Prevalence and burden of HCV co-infection in people living with HIV: A global systematic review and meta-analysis","volume":"16","author":"L Platt","year":"2016","journal-title":"Lancet Infect Dis [Internet]."},{"key":"pone.0278037.ref016","article-title":"HIV, HBV AND HCV co-infected patients\u2019 response to the highly active antiretroviral theraphy in the Volta Region of Ghana","author":"D. Adigbli","year":"2016","journal-title":"Postgraduate Thesis"},{"issue":"6","key":"pone.0278037.ref017","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1097\/01.aids.0000163936.99401.fe","article-title":"Hepatitis B and HIV: Prevalence, AIDS progression, response to highly active antiretroviral therapy and increased mortality in the EuroSIDA cohort","volume":"19","author":"D Konopnicki","year":"2005","journal-title":"Aids"},{"issue":"2","key":"pone.0278037.ref018","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.jhep.2007.11.009","article-title":"Viral hepatitis and HIV coinfection","volume":"48","author":"MS Sulkowski","year":"2008","journal-title":"J Hepatol"},{"issue":"1","key":"pone.0278037.ref019","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1086\/344907","article-title":"Hepatitis C virus and human immunodeficiency virus coinfection in an urban population: Low eligibility for interferon treatment","volume":"36","author":"CA Fleming","year":"2003","journal-title":"Clin Infect Dis"},{"issue":"1","key":"pone.0278037.ref020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12879-017-2422-9","article-title":"Prevalence of hepatitis B and C infection in persons living with HIV enrolled in care in Rwanda.","volume":"17","author":"J Umutesi","year":"2017","journal-title":"BMC Infect Dis"},{"issue":"14","key":"pone.0278037.ref021","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1056\/NEJMra065142","article-title":"Viral Hepatitis in HIV Infection","volume":"356","author":"MJ Koziel","year":"2007","journal-title":"The New England Journal of Medicine"},{"issue":"SUPPL. 5","key":"pone.0278037.ref022","article-title":"Hepatitis B and human immunodeficiency virus coinfection","volume":"49","author":"CL Thio","year":"2009","journal-title":"Hepatology"},{"key":"pone.0278037.ref023","article-title":"UNAIDS Data 2021. Joint United Nations Programme on HIV\/AIDS, Geneva, Switzerland","author":"UNAIDS","year":"2021"},{"issue":"1","key":"pone.0278037.ref024","article-title":"Hepatitis B in Ghana: A systematic review & meta-analysis of prevalence studies (1995\u20132015)","volume":"16","author":"R Ofori-Asenso","year":"2016","journal-title":"BMC Infect Dis [Internet]."},{"issue":"1","key":"pone.0278037.ref025","article-title":"Epidemiology of hepatitis C virus in Ghana: A systematic review and meta-analysis.","volume":"16","author":"AA Agyeman","year":"2016","journal-title":"BMC Infect Dis [Internet]."},{"issue":"1","key":"pone.0278037.ref026","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12981-016-0107-x","article-title":"Prevalence of HIV and hepatitis B coinfection in Ghana: A systematic review and meta-analysis","volume":"13","author":"AA Agyeman","year":"2016","journal-title":"AIDS Res Ther"},{"issue":"1","key":"pone.0278037.ref027","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/01.qai.0000233310.90484.16","article-title":"Mortality in the highly active antiretroviral therapy era: Changing causes of death and disease in the HIV outpatient study","volume":"43","author":"FJ Palella","year":"2006","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"9939","key":"pone.0278037.ref028","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0140-6736(14)60604-8","article-title":"Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): A multicohort collaboration","volume":"384","author":"CJ Smith","year":"2014","journal-title":"Lancet [Internet]."},{"key":"pone.0278037.ref029","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1743-422X-6-202","article-title":"Survey of both Hepatitis B Virus (HBsAg) and Hepatitis C Virus (HCV-Ab) coinfection among HIV positive patients","volume":"6","author":"M Mohammadi","year":"2009","journal-title":"Virol J"},{"issue":"1","key":"pone.0278037.ref030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4102\/sajhivmed.v19i1.737","article-title":"Human immunodeficiency virus infection predictors and genetic diversity of hepatitis B virus and hepatitis C virus co-infections among drug users in three major Kenyan cities","volume":"19","author":"M Oyaro","year":"2018","journal-title":"South Afr J HIV Med"},{"issue":"1","key":"pone.0278037.ref031","doi-asserted-by":"crossref","first-page":"39","DOI":"10.20411\/pai.v4i1.267","article-title":"HBV and HIV\/HBV infected patients have distinct immune exhaustion and apoptotic serum biomarker profiles","volume":"4","author":"MTM Shata","year":"2019","journal-title":"Pathog Immun"},{"issue":"1","key":"pone.0278037.ref032","first-page":"1","article-title":"Gender disparity in epidemiological trend of HIV\/AIDS infection and treatment in Ethiopia.","volume":"76","author":"T Girum","year":"2018","journal-title":"Arch Public Heal"},{"key":"pone.0278037.ref033","unstructured":"AmfAR. Statistics: Women and HIV\/AIDS. amfAR The Foundation for AIDS Research. 2018. https:\/\/www.amfar.org\/about-hiv-and-aids\/facts-and-stats\/statistics\u2014women-and-hiv-aids\/."},{"issue":"1","key":"pone.0278037.ref034","doi-asserted-by":"crossref","first-page":"34","DOI":"10.2174\/1874613601610010034","article-title":"HIV Infection and AIDS in Sub-Saharan Africa: Current Status, Challenges and Opportunities.","volume":"10","author":"ABM Kharsany","year":"2016","journal-title":"Open AIDS J."},{"issue":"3","key":"pone.0278037.ref035","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1080\/09540120903193625","article-title":"Gender differences in antiretroviral treatment outcomes of HIV patients in rural Uganda","volume":"22","author":"W Kipp","year":"2010","journal-title":"AIDS Care\u2014Psychol Socio-Medical Asp AIDS\/HIV"},{"issue":"1","key":"pone.0278037.ref036","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12981-016-0107-x","article-title":"Prevalence of HIV and hepatitis B coinfection in Ghana: A systematic review and meta-analysis","volume":"13","author":"AA Agyeman","year":"2016","journal-title":"AIDS Res Ther"},{"issue":"2","key":"pone.0278037.ref037","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/QAD.0b013e32835a9984","article-title":"Characterization of HIV-HBV coinfection in a multinational HIV-infected cohort","volume":"27","author":"CL Thio","year":"2013","journal-title":"AIDS"},{"issue":"3","key":"pone.0278037.ref038","first-page":"1","article-title":"Hepatitis B and C co-infection in HIV patients from the TREAT Asia HIV observational database: Analysis of risk factors and survival","volume":"11","author":"M Chen","year":"2016","journal-title":"PLoS One"},{"issue":"2","key":"pone.0278037.ref039","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0088552","article-title":"Hepatitis B and C co-infection among HIV-infected adults while on antiretroviral treatment: Long-term survival, CD4 cell count recovery and antiretroviral toxicity in Cambodia.","volume":"9","author":"J Van Griensven","year":"2014","journal-title":"PLoS One"},{"issue":"3","key":"pone.0278037.ref040","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1046\/j.1468-1293.2003.00152.x","article-title":"HIV\/HBV and HIV\/HCV coinfection, and outcomes following highly active antiretroviral therapy","volume":"4","author":"D Lincoln","year":"2003","journal-title":"HIV Medicine"},{"issue":"10","key":"pone.0278037.ref041","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.3748\/wjg.v19.i10.1602","article-title":"Rates and impact of hepatitis on human immunodeficiency virus infection in a large African cohort","volume":"19","author":"N Gwamzhi Ladep","year":"2013","journal-title":"World J Gastroenterol"},{"issue":"8","key":"pone.0278037.ref042","doi-asserted-by":"crossref","DOI":"10.5812\/hepatmon.18128","article-title":"Low prevalence of hepatitis C virus infection among HIV-Positive patients: Data from a large-scale cohort study in Istanbul, Turkey.","volume":"14","author":"O Altuntas Aydin","year":"2014","journal-title":"Hepat Mon"},{"issue":"1","key":"pone.0278037.ref043","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12985-018-1060-1","article-title":"Systematic review and meta-analysis of HIV, HBV and HCV infection prevalence in Sudan","volume":"15","author":"MM Badawi","year":"2018","journal-title":"Virol J"},{"issue":"3","key":"pone.0278037.ref044","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/j.1468-1293.2004.00207.x","article-title":"HIV and hepatitis C coinfection within the CAESAR study","volume":"5","author":"J Amin","year":"2004","journal-title":"HIV Med"},{"issue":"15","key":"pone.0278037.ref045","doi-asserted-by":"crossref","first-page":"7366","DOI":"10.1128\/JVI.00191-09","article-title":"Coinfection with Hepatitis C Virus and Human Immunodeficiency Virus: Virological, Immunological, and Clinical Outcomes","volume":"83","author":"Y Rotman","year":"2009","journal-title":"J Virol"},{"issue":"1","key":"pone.0278037.ref046","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1758-2652-14-22","article-title":"Hepatitis C in HIV-infected individuals: Cure and control, right now","volume":"14","author":"DL Thomas","year":"2011","journal-title":"J Int AIDS Soc [Internet]."},{"issue":"SUPPL. 1","key":"pone.0278037.ref047","first-page":"2005","article-title":"Influence of viral hepatitis on HIV infection","volume":"44","author":"JK Rockstroh","year":"2006","journal-title":"J Hepatol"},{"key":"pone.0278037.ref048","unstructured":"WHO. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: Recommendations for a public health approach (2nd Ed.). World Health Organisation, Geneva, Switzerland. 2016. http:\/\/www.who.int\/hiv\/pub\/arv\/arv-2016\/en\/."},{"key":"pone.0278037.ref049","unstructured":"WHO. Consolidated Strategic information guidelines for HIV in the health sector. World Health Organisation, Geneva, Switzerland. 2015. http:\/\/www.who.int\/hiv\/pub\/guidelines\/strategic-information-guidelines\/en\/."},{"issue":"5","key":"pone.0278037.ref050","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1089\/aid.2013.0208","article-title":"Sex differences in HIV outcomes in the highly active antiretroviral therapy era: A systematic review","volume":"30","author":"JL Castilho","year":"2014","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"1","key":"pone.0278037.ref051","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12879-019-3781-1","article-title":"A superiority of viral load over CD4 cell count when predicting mortality in HIV patients on therapy","volume":"19","author":"C Shoko","year":"2019","journal-title":"BMC Infect Dis"},{"key":"pone.0278037.ref052","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.1016\/j.ijid.2014.07.018","article-title":"Impact of hepatitis B virus infection on HIV response to antiretroviral therapy in a Chinese antiretroviral therapy center","volume":"28","author":"R Yang","year":"2014","journal-title":"Int J Infect Dis [Internet]."}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0278037","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T15:02:00Z","timestamp":1669302120000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0278037"}},"subtitle":[],"editor":[{"given":"Yury E.","family":"Khudyakov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2022,11,23]]},"references-count":52,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2022,11,23]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0278037","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,23]]}}}